Skip to main content

Closed

KURA: Kura Oncology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-443.5%

ROIC-57.5%

Financially safe

Stretched

Debt / equity0.22×

Interest coverage-216.7×

Current ratio6.15×

Kura Oncology, Inc.

KURANASDAQ·USD·Closed

Kura Oncology, Inc.

KURANASDAQ·USD·Closed

$9.01

−3.22%

$9.01

−$0.30 (3.22%)

52W Range

51thpctl

Volume

0.65×avg

Mkt Cap

799.86MUSD

P/E

-2.7TTM

Div Yield

–ann

52W Range

51thpctl

Volume

0.65×avg

Market Cap

799.86MUSD

P/E Ratio

-2.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings